Business Description
Relay Therapeutics is a Cambridge, Massachusetts-based clinical-stage company focused on discovering new drugs to treat certain cancers and genetic diseases. Its main drug candidates target breast cancer, solid tumors, vascular malformations, and Fabry disease, with additional programs aimed at key cancer-driving proteins. The company works with partners including Pfizer, Elevar Therapeutics, and D. E. Shaw Research, using advanced computer modeling of protein behavior to guide its drug development efforts.
